Protein‐free synthetic surfactant for the prevention and treatment of respiratory distress syndrome in neonates
Visualizar/ Abrir
Data
2017-10-24Autor(es)
Rojas Reyes, María XimenaBuitrago Lopez, Adriana Danuby
Lasalvia, Pieralessandro
R., Soll
E., Özek
Autor(es) Corporativo(s)
Pontificia Universidad Javeriana. Facultad de Medicina. Instituto de Genética Humana
Tipo
Artículo de revista
ISSN
1469-493X
Páginas
1-9
Compartilhe este registro
Citación
Metadata
Mostrar registro completo
Documentos PDF
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To evaluate the effectiveness of intratracheal administration of synthetic protein‐free pulmonary surfactant in neonates at risk of developing RDS or with established RDS.
Comparison 1: Does intratracheal administration of synthetic protein‐free pulmonary surfactant compared to air placebo or normal saline or no treatment reduce mortality and other complications of preterm birth in preterm infants at risk of developing RDS?
Comparison 2: Does intratracheal administration of synthetic protein‐free pulmonary surfactant compared to air placebo or normal saline or no treatment reduce mortality and other complications of preterm birth in preterm infants with clinical and/or radiologic evidence of respiratory distress syndrome requiring assisted ventilation?
Link para o recurso
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012821/fullFonte
Cochrane Database of Systematic Reviews; (2017)
Google Analytics Statistics
Collections
- Artículos [485]